Donald A. Denkhaus, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 20,000 shares at $3.41 ($68K) on 2018-06-08, disclosed to the SEC on 2018-06-11.
Open-market purchase of $68k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CPRX | BUY | 2018-12-28 | $48K | — | Filing → |
| CPRX | BUY | 2018-12-17 | $149K | — | Filing → |
| CPRX | BUY | 2018-05-31 | $75K | — | Filing → |